Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study
Oral Squamous Cell Carcinoma
About this trial
This is an interventional diagnostic trial for Oral Squamous Cell Carcinoma
Eligibility Criteria
Inclusion Criteria:
- In vitro studies.
- Samples used are oral dysplasia and squamous cell carcinoma.
- Diagnostic accuracy of Bmi-1 marker on oral dysplasia and SCC.
- English language published articles only.
Exclusion Criteria:
- In vivo studies.
- Studies using any techniques other than immunohistochemistry or PCR.
- Samples using any carcinoma rather than squamous cell carcinoma.
- Samples using benign tumors.
- Samples using sarcomas.
Sites / Locations
- Asmaa M. Abou Gabal
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
Immunohistochemistry
Polymerase Chain Reaction PCR
In order to provide more precised data on Bmi-1 immunoexpression in OSCC, image analyzer will be used. The data will be obtained using the software (SIS, Germany), which comprise a light microscope (Olympus B × 60 Japan) capable of performing high speed digital image processing for the purpose of cell measurements. It will be calibrated automatically to convert the measurement units (pixels) produced by image analyzer program into actual micrometer units.
Calculation of Relative Quantification (RQ) (relative expression): After the RT-PCR will run, the data will be expressed in Cycle threshold (Ct).PCR data sheets will include Ct values of assessed gene and the house keeping (reference) gene which will be continuously expressed in the cell- (β-actin).To measure the gene expression of certain gene, -ve control sample shall be used. So target gene expression will be assessed and related to reference (internal control) gene as follows: Finally, RQ was calculated according to the following equation: ∆ Ct (Cycle threshold) = Ct assessed gene - Ct reference gene ∆∆ Ct = ∆ Ct sample - Ct control gene RQ = 2-(∆∆Ct)